Patents by Inventor Harald SUROWY

Harald SUROWY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tumor marker for the rhabdomyosarcoma
    Patent number: 11058777
    Abstract: The present invention relates to a nucleic acid molecule which encodes a splice variant of the human P2RX7 receptor, and nucleic acid molecules derived therefrom, a recombinant vector containing said nucleic acid molecules, a host containing said recombinant vector, a polypeptide encoded by said nucleic acid molecules, a host cell expressing said polypeptide, a binding molecule binding to said polypeptide, a pharmaceutical composition comprising said binding molecule, a method for the production of the isolated polypeptide, and other methods and uses in connection therewith.
    Type: Grant
    Filed: May 17, 2018
    Date of Patent: July 13, 2021
    Assignees: EBERHARD KARLS UNIVERSITÄT TUEBINGEN MEDIZINISCHE FAKULTAET, DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS
    Inventors: Jens Gesche, Sorin Armeanu-Ebinger, Guido Seitz, Harald Surowy
  • Synthesis of double-stranded nucleic acids
    Patent number: 10988795
    Abstract: The present invention relates to a method for the synthesis of double-stranded nucleic acids from a wide variety of samples and comprises the use of these nucleic acids for deep sequence analysis. Also, the present invention relates to specific reagents used in the method of the present invention. Further, the invention relates to kits comprising reagents for the method of the invention and use of said kits.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: April 27, 2021
    Inventors: Andrey Turchinovich, Harald Surowy, Barbara Burwinkel
  • SYNTHESIS OF DOUBLE-STRANDED NUCLEIC ACIDS
    Publication number: 20190032110
    Abstract: The present invention relates to a method for the synthesis of double-stranded nucleic acids from a wide variety of samples and comprises the use of these nucleic acids for deep sequence analysis. Also, the present invention relates to specific reagents used in the method of the present invention. Further, the invention relates to kits comprising reagents for the method of the invention and use of said kits.
    Type: Application
    Filed: May 15, 2015
    Publication date: January 31, 2019
    Inventors: Andrey TURCHINOVICH, Harald SUROWY, Barbara BURWINKEL
  • NEW TUMOR MARKER FOR THE RHABDOMYOSARCOMA
    Publication number: 20180256743
    Abstract: The present invention relates to a nucleic acid molecule which encodes a splice variant of the human P2RX7 receptor, and nucleic acid molecules derived therefrom, a recombinant vector containing said nucleic acid molecules, a host containing said recombinant vector, a polypeptide encoded by said nucleic acid molecules, a host cell expressing said polypeptide, a binding molecule binding to said polypeptide, a pharmaceutical composition comprising said binding molecule, a method for the production of the isolated polypeptide, and other methods and uses in connection therewith.
    Type: Application
    Filed: May 17, 2018
    Publication date: September 13, 2018
    Inventors: Jens GESCHE, Sorin ARMEANU-EBINGER, Guido SEITZ, Harald SUROWY